Amphastar: Higher Costs, Lower Growth, And A 'Value Trap' Label

Amphastar Pharmaceuticals (AMPH) stays a Hold as generics decline, margins compress, and FY26 guidance is cut.

The Closest Thing to a Time Machine: My Top 3 Reasons I Love Earnings

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I was ten years old the first time I saw Back to the Future in a movie ...

Commanders offensive coaching staff rounds into shape with a promotion and a newly-hired coach

A collection of articles, podcasts & tweets from around the web to keep you in touch with the Commanders, the NFC East, the ...

Profits vs. Earnings: Key Differences Explained

Discover how profits and earnings differ and their significance in financial statements, alongside key metrics like net profit and EBITDA.

Block Eliminates Bloat To Deliver Ambitious 2028 Target - Wait For Correction

Block rallies after a 40% headcount cut, strong Q4 2025 results, and raised FY2026 guidance. Find out why I rate XYZ stock a ...

Kimbell Royalty Q4 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported fourth-quarter results that management said capped “another outstanding year” for the mineral and royalty owner, highlighting organic production growth versus the ...